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ABSTRACT 
 
 
Bovine Viral Diarrhea Virus (BVDV) is a component of bovine respiratory disease 
complex, which has been reported to cause the largest loss in productivity in feedlot cattle in the 
U.S., with annual economic losses in excess of $1.5 billion USD. The genetic influences and 
losses associated with BVDV challenge on carcass traits in controlled herds are not documented. 
This study evaluated individual animal effects in the first 14 days following challenge with  
BVDV Type 1b for carcass trait differences. 
Nellore-Angus (Bos indicus-Bos taurus) F2 and F3 crossbred steers (n = 363) were 
evaluated for clinical symptoms, body weights, and rectal temperatures immediately following 
challenge. Crosses and sire lines were balanced across the vaccine treatment groups of non-
vaccinated control (NON), killed virus vaccinated (KV), or modified-live virus vaccinated 
(MLV).  
Hot carcass weight (HCW), adjusted fat thickness (AFT), longissimus muscle area 
(REA), and marbling score (MARB) were analyzed through mixed models with sire and 
pen(year) as random effects; fixed effects of vaccine, type of cross, pyrexia status (rectal 
temperature >40 C at least once), clinical symptom presentation, and levels of feed intake and 
ADG 14 d post-challenge were investigated. Vaccine influenced AFT (P = 0.016), where MLV 
steers had 0.26 cm less fat than KV steers. Marbling was affected by type of cross (P = 0.023) 
with up to 0.60 marbling scores higher (P < 0.05) in some parental combinations; an interaction 
between type of cross and pyrexia status also affected MARB (P = 0.017), with one parental 
combination having higher MARB associated with pyrexia. HCW was not affected by pyrexia, 
but was affected by feed intake (P = 0.019), with steers in the highest vs. lowest category 
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averaging 24.0 kg heavier. No animals presented morbidity symptoms severe enough to warrant 
potential therapeutic treatment, animals with mild clinical symptoms in the 14 d window post 
BVDV challenge had 4.98 cm2 lower REA (P = 0.012). This study affirms the complexity of 
health impacts on beef carcass traits and the need for study of subclinical illness in beef 
production systems, particularly regarding BVDV.  
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INTRODUCTION 
 
Bovine Respiratory Disease Complex (BRDC) is the largest cause of morbidity 
and mortality in the feedlot environment annually. BRDC is multifactorial, and used to 
describe illness from the group of viral and bacterial pathogens associated with 
respiratory symptoms, including Bovine Viral Diarrhea Virus (BVDV), which this study 
will focus on. This virus manifests as the illness known as bovine viral diarrhea (BVD). 
While not all BVD cases are detected due to subclinical illness, clinically ill animals can 
be detected through common symptoms that include pyrexia (fever), nasal and ocular 
discharge, and decreased performance (Zoetis, 2018). The majority of cases of 
BVD/BRD will be diagnosed early in the feeding period (Smith, 1998; Sanderson et al., 
2008), when cattle are experiencing high levels of stress due to transport, transition to 
new diets, and animal processing events following feedlot arrival. This leads to the need 
to evaluate and identify novel ways to diagnose animals earlier, before animal well-
being is compromised, and losses associated with morbidity occur.  
Bovine Viral Diarrhea is immunosuppressive, and often leads to comorbidity 
with the bacterial pathogens associated with BRD (APHIS, 2007). While infection with 
BRD typically does not cause mortality, in all cases, it poses a significant risk of loss of 
overall animal well-being, as well as production and economic losses (McNeill, 1999). 
Even though the majority of feedlots utilize at least one respiratory vaccine to combat 
BRD (USDA, 2011), the average incidence of BRDC remains at 16.2% (Neibergs et al., 
2014). Regardless of number of animals treated for BRD clinical symptoms across 
studies, it has been noted that many animals are subclinically ill, and only diagnosed 
after slaughter by the presence of lung lesions, produced through comorbidity with 
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bacterial pathogens (Gardner et al., 1999; Snowder et al., 2005; Schneider et al., 2009; 
Griffin, 2014), leading to a large variation in rates of morbidity among literature reports. 
Other sources of variation in rates of morbidity include age of dam, vaccine protocol, 
and individual animal genetics (Schunicht et al., 2003; Snowder et al., 2005; Snowder et 
al., 2006; Ridpath et al., 2007; Da Silva et al., 2016) 
Morbidity events during the feeding period influence feeding behavior and 
carcass merit, showing that feeding behavior may be an indicator of an animal’s 
compromised health status, even if that animal is not presenting clinical symptoms. 
Animals experiencing illness associated with BRD have been shown to have fewer bunk 
visits, lower intake, lower average daily gain (ADG), and increased feed cost associated 
with greater days on feed (Sowell et al., 1999; Kayser and Hill, 2013; Smith et al., 
2017). These in turn lead to lower marbling scores, lower carcass weights, and lower 
ribeye areas associated with BRD morbidity (Reinhardt et al., 2012; Waggoner et al., 
2007; Runyan et al., 2014; Gardner et al., 1999), which translates to the relationship that 
morbid animals can not only have higher production costs associated with higher 
medicine costs, they can also have lower carcass value (McNeill, 1999). Therefore, if an 
animal becomes morbid, it is likely that feeding behavior will be negatively impacted, 
which can then lead to poorer carcass outcomes.  
The hypothesis for the present study, then, is that morbidity early in the feeding 
period, will influence traditional carcass measurements (Gardner et al., 1999; Waggoner 
et al., 2007; Reinhardt et al., 2012; Runyan et al., 2014). Therefore, the objectives for 
this study were to utlize a BVDV standardized challenge model and: (1) evaluate the 
effect of average daily gain and dry matter intake immediately after BVDV exposure on 
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traditional carcass measurements, (2) utilize individual animal information such as breed 
composition and age of dam to explain variation among carcass measurements, (3) 
investigate the effect of BRD vaccine protocol and traditional health response 
measurements such as presence of clinical symptoms and pyrexia following BVDV 
exposure on carcass outcomes, and (4) evaluate possible relationships among the 
variables of lung scores, clinical symptoms, average daily gain classification, intake 
classification, and animal temperament classification regarding responses to BVDV 
exposure.  
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LITERATURE REVIEW 
Animal Response to Bovine Respiratory Disease Pathogens 
Even though Bovine Respiratory Disease Complex (BRDC) is credited with 
being the largest reported loss of productivity in feedlot animals, this complex is made 
up of many illnesses. One of the most prevalent of these is Bovine Viral Diarrhea 
(BVD), which is caused by the Bovine Viral Diarrhea Virus (BVDV). While BVDV 
causes varied immune reactions, due to variation in host susceptibility and the virulence 
of the particular strain in question. Clinical symptoms may include fever, nasal and 
ocular discharge, and diarrhea (Zoetis, 2018). There are multiple variants of BVDV, 
with viruses falling into two subtypes, either BVDV subtype 1 or subtype 2, and being 
further classified as cytopathogenic or noncytopathogenic, with many individual 
genotypes within each of these categories, based on cell culture characteristics in vitro 
(Brodersen, 2014). This virus is immunosuppressive, and interacts with both innate and 
adaptive immunity. In acute infections, viremia typically resolves within 15 days, 
following a 5 to 7 day incubation period (Baker, 1995). Severe illness from BRD can 
also cause lung lesions (Wittum et al., 1996), which are associated with lower average 
daily gain, lower hot carcass weight, less internal fat, and lower marbling scores 
(Gardner et al., 1999).  
Even though there are two subtypes of BVDV, type 1 and type 2, with both 
having cytopathogenic and noncytopathogenic strains, both can create the same 
manifestations of disease symptoms (Brodersen, 2014). In addition to being 
immunosuppressive, noncytopathic BVDVs have the ability to cross the placental barrier 
and create persistently infected (PI) animals, who will shed the virus their entire life. 
  5 
While the mechanism that creates persistently infected animals is not clearly defined at 
this time, it has been observed that the window for persistent infection occurs from d 40 
to 120 in utero (Bolin, 1995). It has been hypothesized by Peterhans et al. (2003), that 
interferon- may be driving the inability of BVDV to establish PI in fetuses before d 40 
of gestation, as Alexenko et al. (1999) showed that interferon- can have antiviral 
activity similar to other type 1 interferons. Similarly, Peterhans et al. (2003) has 
hypothesized that fetuses greater than 120 d of gestation produce their own interferons, 
protecting them from persistent infection.  
Even though the efficacy of BRD vaccines is the subject of much research and 
debate, particularly between the findings of studies that utilize a natural exposure model 
and those that utilize a challenge model (Theurer et al., 2015), they are used in 96.6% of 
feedlot operations (USDA, 2011). Runyan et al. (2014) showed with previous research in 
the same cattle as this project, that vaccination protocols, regardless of type (killed virus 
or modified-live virus), improved animal performance following BVDV challenge even 
when clinical symptoms were not observed. Moreover, it was suggested by Smith et al. 
(2017) that a modified live BVD vaccine may mitigate the negative feeding performance 
effects of a directly administered BVDV challenge more effectively than killed virus or 
non-vaccination. Ridpath et al. (2007) hypothesized that poor vaccine efficacy may be 
due to variation among BVDV strains. It was also suggested by Ridpath et al. (2007) that 
individual vaccines may be more effective than others, even when comparing modified-
live virus (MLV) vaccines to one another, likely due to strain differences. Fulton et al. 
(2002) noted that most BRD vaccines contained BVDV type 1a strains, which may not 
confer protection against type 1b challenge.  
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Effects of BRD vaccines on carcass traits are not widely reported, except through 
corresponding animal health differences. Schunicht et al. (2003) observed that crossbred 
bull and steer calves of approximately 8 to 10 months of age in a typical commercial 
feedlot setting, had carcass weight differences due to vaccine treatment. Animals 
receiving a univalent MLV vaccine only containing only infectious bovine 
rhinotracheitis (IBR) antigen had 2.8 kg lower carcass weights than animals receiving 
multivalent MLV vaccines containing IBR, parainfluenza-3 (PI-3), BVDV, and bovine 
respiratory syncytial virus (BRSV). Additionally, lower rates of fever were seen in 
animals receiving a multivalent vaccine when compared to animals receiving a univalent 
vaccine, leading to lower rates of treatment for BRD symptoms. These led to a $0.74 per 
animal advantage for animals receiving a multivalent vaccine, suggesting that it is more 
cost-effective to utilize multivalent vaccines 
Often, animals with BRD are clinically asymptomatic, as evidenced by lung 
lesions present in nearly equal frequencies between animals that were treated for signs of 
respiratory infection, vs. those that were not (Gardner et al., 1999; Wittum et al., 1996). 
Downey-Slinker et al. (2016) described that 41% of the Angus-Nellore steers used in the 
present study showed thrombocytopenia, 55% showed lymphopenia following BVDV 
challenge. Even though both of these traits are symptoms of BVDV infection, only 14% 
of animals exhibited clinical symptoms, with all cases being mild. This gives credit to 
statements by multiple authors that phenotypic complexity and unobservable subclinical 
symptoms are likely key contributors to low heritability estimates for BRD susceptibility 
based on “healthy vs. morbid” classification, as well as being a root cause for un-
improving morbidity rates in the field (Snowder et al., 2006; Neibergs et al., 2014; 
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Runyan et al. 2014). 
Feeding Behavior and Economic Impacts of BRD 
Sowell et al. (1999) reported through two trials that feeding behaviors between 
healthy and morbid feedlot steers were different. Healthy steers spent an average of 60 
minutes per day at the feed bunk, compared to 46 minutes in morbid steers (trial 1). 
However, watering behavior did not differ during the first four days of the feeding 
period, but healthy calves had 1.4 more drinking bouts per day than morbid calves for 
the entire feeding period. Smith et al. (2017) found in steers of this study that dry matter 
intake (DMI) decreased following BVDV type 1b challenge. When this is combined 
with the results of Kayser and Hill (2013) that animals who consumed less had lower 
average daily gain, it can be assumed that at an equal number of days on feed, animals 
who are morbid will have lower live weights, and thus, lower carcass weights, as seen in 
the results of the Texas Ranch to Rail program (McNeill, 1999). These data showed that 
morbid cattle had medicine costs that were approximately $26 per head higher than 
healthy calves, while gaining an average of 0.19 kg/d less than healthy calves, and 
having lower-grading carcasses than their non-morbid counterparts, leading to a 5-year 
average loss of $93.20 per morbid animal (McNeill, 1999). Griffin (1997) estimated that 
animal deaths associated with bovine respiratory disease approach $1 billion of loss to 
producers. Adjusted for inflation using data from the Bureau of Labor Statistics (BLS, 
2018) from 1997 to July 2018, it can be extrapolated that these losses would be valued at 
$1.57 billion in 2018-2019.  
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Relationships of Health Influences on Animal Performance and Carcass Outcomes 
Reinhardt et al. (2012) found that a higher number of health treatments in morbid 
Angus feedlot steers was negatively correlated with carcass traits such as hot carcass 
weight, with steers not identified as needing BRD therapeutic treatment having an 
average of 373.2 kg carcasses, compared to 360.9 kg for steers requiring treatment three 
or more times. Additionally, carcass quality was impacted, with no roll cattle requiring 
twice as many BRD therapeutic treatments on average compared to cattle that graded 
prime or choice. This coincides with the findings by Gardner et al. (1999) and Waggoner 
et al. (2007), that steers treated for respiratory infection more than once had an average 
daily gain of 0.61 kg, compared to 0.695 kg in animals who were not identified for 
treatment. In addition, steers treated once or less than once had 82.4% of carcasses grade 
choice, compared to 76.9% of carcasses in steers treated more than once. This is further 
substantiated by Runyan et al. (2014), who observed reduced average daily gain in the 
first 14 d following a prescribed BVDV challenge in the Angus-Nellore steers used in 
the present study. Additionally, Gardner et al. (1999) found that steers without lung 
lesions present at slaughter had Warner-Bratzler shear force values of 2.8 kg, compared 
to 3.0 kg in steers than those that had active lung lesions.  
While Waggoner et al. (2007) did not find a difference in hot carcass weight, fat 
thickness, longissimus muscle area, marbling score, or yield grade between steers not 
identified as needing treatment and steers presenting with, and subsequently treated for, 
clinical symptoms decreased profitability (attributed to a greater number in days on 
feed). It was found that steers not presenting with, and subsequently not treated for 
clinical signs of BRD returned $92.26 more profit on average than steers treated one or 
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more times, and also found a relationship among profitability between steers with those 
who were treated once bringing a higher price on average than steers who were treated 
two or more times (Waggoner et al., 2007). This number may in reality be higher, as it 
did not include any differences in feed cost for healthy versus morbid animals. 
 It was suggested by Waggoner et al. (2007), that delaying harvest of steers that 
were treated would possibly allow for overall carcass composition to recover to a level 
similar to cohort animals that were not treated. However, this would require a cost-
benefit analysis by the producer at the time of decision in order to determine if the 
increased carcass value would be greater or less than the cost required to feed and house 
the animal for the extended time, and would also require a risk analysis in order to 
determine the probability of repeated morbidity during the extended feeding period. 
Moreover, this idea was contradicted by Wilson et al. (2017), with findings that despite a 
greater number of days on feed in order to reach a similar endpoint to nonmorbid 
animals, morbid animals had lower hot carcass weights, marbling scores, and loin 
muscle area, with all values decreasing linearly, corresponding with 0 to 4 treatments 
administered, and slaughtered at a common backfat thickness. 
Vaccine treatment has also been found to be important to feeding behavior post-
challenge. According to Smith et al. (2017), the challenged Angus-Nellore steers in the 
present study that received a modified live virus experienced a lower reduction in feed 
intake when compared to steers who received a killed virus or were not treated with a 
vaccine. This was coupled with, and likely driven by steers who received a modified live 
virus vaccine having a greater duration of bunk visit events, greater meal frequencies, 
and slower eating rates when compared to steers who received a killed virus or no 
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vaccine treatment. Whether these differences could carry over to impacts on carcass 
traits is unknown, however. Ridpath et al. (2010) and Ridpath (2013) found that 
modified live vaccines also caused lower levels of lymphocyte decline, with  lower 
levels of antibodies, showing lowest levels of pyrexia (presenting >40 C rectal 
temperature at any time). However, it was noted that modified live vaccines were no 
more effective than killed vaccines when it comes to preventing viremia (Ridpath et al. 
2010).  
In a companion analysis to the present study, animals who received a modified 
live virus vaccine treatment for BVD showed lower antibody titers for BVD and IBR 
and less pronounced lymphocytopenia and thrombocytopenia at 14 d after BVDV 
challenge, when compared to animals who received a killed virus vaccine (Downey-
Slinker et al., 2016). However, there has been variation shown among groups of cattle 
receiving different types of modified-live vaccines. Bryant et al. (2008), among steers 
receiving modified-live vaccines, found that steers receiving Pyramid 5 (Bohringer 
Ingelheim, Ridgefield, CT, U.S.) vaccines had different relapse rates of BRD symptoms 
than steers receiving Bovi-shield Gold 5 (Zoetis, Parsnippany Hills, NY, U.S.) and 
Bovi-shield IBR-BVD (Zoetis, Parsnippany Hills, NY, U.S.), with 4.2% and 3.6% lower 
relapse rates, respectively. 
Genetic Components of BRD Incidence 
While the effects of hybrid vigor are well documented for overall animal health 
(Bunning et al., 2018), it is notable that in a study by Snowder et al. (2005), incidence of 
BRD was less in Bos taurus crossbred compared to purebred steers. Additionally, 
Reinhardt et al. (2009) found that Continental steers required an average of 0.15 
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therapeutic treatments for BRD per animal, compared to 0.08 average therapeutic 
treatments for English or English and Continental cross steers in a typical feedlot 
environment, with all groups having various ages of steers. Furthermore, crosses 
containing British by Continental or the tropically adapted breeds of Brahman, Boran, 
and Nellore, which exhibited lower incidence of BRD when compared to calves created 
through crossing two British breeds (Snowder et al., 2005). In another study, Snowder et 
al. (2006) found that some breeds were generally more susceptible to BRD than others 
with  clinically observed incidence rates ranging from 8.34% in Hereford, to 18.85% in 
Braunvieh. These breed differences imply there are genetic components for BRD 
resistance or susceptibility, and from there, selection could be used to reduce incidence 
throughout the population. However, it may be possible that breeds with lower observed 
incidence of BRD may simply be better at masking symptoms, as subclinical illness was 
not quantified in Snowder’s study. Hilton (2014) identified selection as a potentially 
effective way to decrease BRD susceptibility without additional intervention.  
Even though a clinical phenotype may not be a reliable indicator of true level 
illness when compared to subclinical phenotypes, phenotypic selection for increased 
population resistance to BRD may be a successful practice over time. As previously 
discussed, even though subclinical animals are not reliably detected in many studies until 
slaughter, animals that present clinical symptoms do have reduced performance from 
those that are subclinical or healthy (Waggoner et al., 2007; Reinhardt et al., 2012), with 
subclinically ill animals having lower performance than animals that remain healthy 
(Gardner et al., 1999), suggesting that selection against clinical phenotypes may be 
successful in selecting for animals with greater resistance to BRD pathogens. However, 
  12 
some producers may be inadvertently selecting against it already. In broiler lines 
selected for a higher rate of growth, lower antibody responses were seen to sheep 
erythrocytes when compared to a line selected for lower body weight (Miller et al., 
1992). In a meta-analysis of similar projects by van der Most et al. (2010), lines of 
poultry that had been selected for increased growth showed decreases in immune 
function, but among lines of poultry selected for immune function, the effect on growth 
was near zero. If a similar relationship were found in beef cattle, it would mean that as 
producers place emphasis on growth traits they could be inadvertently, but 
simultaneously, suppressing immune function. 
 This idea may explain some of the increase observed in an analysis by 
Loneragan et al. (2001), where it was found that cattle had relative risks of 1.16, 1.35, 
and 1.46 for mortality due to respiratory tract disorders compared to cattle in the 
reference year, in 3 out of 5 years, along with overall mortality increasing from 10.3 
deaths to 14.2 deaths per 1000 cattle. This finding occurred during a time in which post 
weaning gain has increased (Angus Association, 2019). In a study by Miles (2009), it 
was found that comparing medicine cost per head and % death loss from 1989 to 2008, it 
was found that in cattle weighing between 295and 408 kg, medicine costs have increased 
from approximately $1.25/animal in 1989 to $3.00/animal in 2008. In the same study, it 
was found that average death loss in 295 to 408 kg animals increased from 0.75% in 
1989 to just over 1.00% in 2008 (Miles, 2009). While some of this is due to an increase 
in drug costs, it is believed that cattle are heavier per day of age, requiring a greater 
amount of these drugs to be used per treatment event (Miles, 2009).   
  13 
Neibergs et al. (2014) found that with an average BRD complex (BRDC) 
prevalence of 16.2% in U.S. feedlots with a capacity greater than 1,000 head, the 
average rates of genetic change for susceptibility to BRDC when selecting the top 30% 
of individuals were 2.08%, as defined by clinical scores in a quantitative scoring system. 
This study also estimated heritability at 0.292, which corresponds to the highest value of 
0.26, found by Snowder et al. (2005). However, Snowder et al. also reported that the low 
estimates of heritability may be related to the large variation in clinical symptoms, or 
measurement error of disease detection. This is concept supported by Wittum et al. 
(1996), who reported that only 50% of all steers with pulmonary lesions at slaughter had 
been detected as having BRD symptoms during the feeding period. Similar results have 
been reported in studies by Gardner et al. (1999) as well as Thompson et al. (2006), with 
29% and 29.7% of cattle not treated for BRD clinical symptoms presenting with lung 
lesions, respectively. Overall, a highly successful method of managing BRD and BVDV 
outbreaks is preventing them in the first place. While the use of vaccinations for 
prophylaxis and individual animal treatment plans are in place in many operations, 
identifying and utilizing a sufficient number of animals that are resistant or tolerant to 
both the viral and bacterial components of BRD, in order to decrease the spread to 
susceptible animals will be a critical tool in shifting the paradigm from one of reactivity 
to one of proactivity.  
As stated previously, the type of vaccine also seems to be highly influential in 
immune response and overall ability of the animal to ward off the virus. These vaccines 
also seem to play a role in subsequent immune challenges, and gene regulation in treated 
animals. The results of Downey-Slinker et al. (2016) point toward modified live virus 
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vaccines as a better option when considering future challenges. However, as 
demonstrated in Bryant et al. (2008), even variation within vaccines of the same type can 
exist. Among three different types of modified-live virus vaccines, trends were seen for 
steers receiving Pyramid 5 (Bohringer Ingelheim, Ridgefield, CT, U.S.) had 3.8% 
better feed conversion than animals receiving Bovi-Shield Gold IBR-BVD (Zoetis, 
Parsnippany Hills, NY, U.S.) vaccine. A similar trend was also identified for morbidity 
rates, with animals receiving Pyramid 5 (Bohringer Ingelheim, Ridgefield, CT, U.S.) 
having 11% fewer cases of morbidity when compared to animals receiving Bovi-Shield 
Gold 5 (Zoetis, Parsnippany Hills, NY, U.S.), as well as a 22% lower relapse rate.  
Temperament and Handling on Animal Responses 
Individual temperament and animal handling may also contribute to 
susceptibility to illness, altered feeding behavior, and carcass outcomes (Fell et al., 1999; 
Smith et al., 2017;  Olson et al., 2019). Fell et al. (1999) found that calm cattle 
performed better in the feedlot than nervous cattle, gaining 1.46 kg/day and 0.95 kg/day, 
respectively. Moreover, no calm animals were identified for health problems, whereas 5 
of 12 nervous animals were taken to the hospital pen at some point during the feeding 
period (Fell et al. 1999). While temperament may be highly variable from one animal to 
the next, it has been shown to be moderately heritable (Le Niendre et al., 2002), 
indicating that selection for docile animals could improve their susceptibility to 
morbidity, and improve carcass outcomes. Riley et al. (2014) found overall heritability 
for temperament traits to be 0.47 to 0.55 in Nellore-Angus crosses, based on model used. 
Defining a ‘favorable’ phenotype for animal temperament may depend upon the 
production phase of that animal. For cow-calf operators in more extensive situations, it is 
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advantageous to select for cows with protective maternal temperament, which leads to 
greater rates of calf survival (Grandinson, 2005), even though cows with a temperament 
that is too excitable at breeding may experience reduced pregnancy rates, and be difficult 
to handle (Cooke, 2014). However, once the offspring of these cows reach the feedlot, 
an excitable temperament is less advantageous (Bates et al., 2014).  
It was suggested by Curley et al. (2007), that higher concentrations of base-level 
serum cortisol seen in excitable cattle, as well as elevated cortisol levels that last longer, 
could mean that easily excitable cattle experience chronic stress, leading to suppressed 
immune systems, as well as decreased deposition of protein and fat when compared to 
their non-excitable counterparts. Bates et al. (2014) studied the interactions between 
temperament and growth traits, and found that excitable cattle gain less in a feedlot 
setting, based on the observed correlation of -0.117 between total gain and chute exit 
velocity. Fang et al. (2012) identified small to moderate correlations involving 
temperament with antibody titers and hematological responses post BVDV challenge in 
these steers. Bates et al. (2014) also found that cattle can be identified upon entry into 
the feedlot through chute score, which was also found to have a negative correlation with 
marbling score. This information could potentially be utilized to group excitable cattle 
together, who may have a higher risk of being immunocompromised, such as 
acclimating excitable animals to human handling. 
 It was found by Cooke (2014) that animals were able to acclimate to human 
handling in order to reduce circulating blood plasma cortisol in animals in feedlot 
environments. This finding could be effective at reducing the incidence of the BRD 
complex. Due to their nature, excitable animals may experience increased and prolonged 
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stress responses when compared to their non-excitable contemporaries, particularly 
during handling events in novel environments such as a feedlot. 
 Regardless of excitability, handling can cause stress to cattle, and even 
appropriate handling events can cause variable stress levels among animals, depending 
on the animal’s perception of the handling experience (Grandin and Shivley, 2015). 
Stress can cause cattle to deplete glycogen stores before slaughter, leading to dark 
cutting carcasses (McVeigh et al., 1982), which are largely discounted by packers. 
Moreover, it was found by Fordyce et al. (1985) that there was a tendency for bruising 
and temperament score to be related, indicating that docile cattle experienced less 
carcass bruising than their excitable contemporaries, and was speculated that this was a 
function of an animals’ own temperament, rather than their herd mates. 
Dam Effects on Health and Carcass Traits 
 While age of dam effects and adjustments for birth and weaning weights have 
been widely accepted, these potential effects on calf immunity and feeding performance 
have not been as broadly discussed. Wittum and Perino (1995) quantified the effects of 
passive immunity on calves before and after weaning, as well as growth performance of 
calves finished in a typical feedlot environment. IgG concentrations in calves have been 
shown to be influenced by age of dam, with IgG levels increasing as age of dam 
increased (Muggli et al., 1984). Wittum and Perino (1995) found that calves 
experiencing morbidity and mortality due to BRD prior to weaning also fell into groups 
with the lowest concentrations of serum IgG and plasma proteins taken from samples 
taken 24 hours postpartum. Furthermore, calves with inadequate plasma protein 
concentrations at 24 hours of age were associated with approximately 3 times greater 
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risk of respiratory tract morbidity in the feedlot (Wittum and Perino, 1995). These results 
indicate that as a dam ages, her offspring should have a lowered risk of respiratory tract 
morbidity when compared to calves with younger dams.  
Beef Improvement Federation (BIF) guidelines (BIF, 2018) describe a 
relationship of age of dam to birth weight, weaning weights, but do not describe any 
relationship beyond weaning, as these influences are usually thought to be not 
significant. However, Da Silva et al. (2016) found that the effect of dam’s age is present 
among carcass traits, as well, indicating that carryover effects of age of dam should be 
considered. Da Silva et al. (2016) found that steers born to 2 or 3-year-old dams had 
lighter carcasses, with more carcasses grading Choice and upper 2/3 Choice. 
Additionally, final body weights and hot carcass weights were higher for steers born to 
dams 4 to 9 years of age, with overall body weights, ribeye area, and hot carcass weights 
increasing until dams reached 7 to 8 years of age, at which point offspring performance 
began to decline. This relationship may be partially explained by overall maturity of the 
dam and her corresponding body size. Younger females who are still developing will not 
be at their mature weight, which is likely influencing the weight of calves at birth. 
Similarly, body weight of females beyond 8 years of age may begin to decline when 
compared to females within the 5-8 years of age group.  
Summary 
Feedlot cattle experience a host of stressors, including immune challenges and 
many novel experiences, such as feedstuffs and feeding situations, various animal 
handling styles and physical environments that can affect performance traits. 
Additionally, some animals have poor genetic predisposition to lowered feedlot 
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performance when compared to contemporaries, leading to potential interactions 
between genetic and environmental components, which add variability to various 
phenotypes for performance traits. Regardless, effects of bovine respiratory disease 
complex continue to be a large economic burden on the cattle industry. Cow-calf 
producers could benefit from lowered BRD incidence through selection for appropriate 
temperament and resilience to BRD pathogens; at least part of this resilience may be 
recognized through evaluation of traditional performance traits such as ADG and feed 
intake, which could be utilized to identify morbid animals, which in turn influence 
carcass merit.  
The hypothesis for the present study, then, is that morbidity indicators early in 
the feeding period in response to BVDV exposure, will influence traditional carcass 
measurements in a fashion similar to what has been reported in other studies for 
generalized BRDC (Gardner et al., 1999; Waggoner et al., 2007; Reinhardt et al., 2012; 
Runyan et al., 2014). Therefore, the objectives for this study were to utilize a defined 
BVDV challenge model to: (1) evaluate the effect of average daily gain and dry matter 
intake immediately after BVDV exposure on traditional carcass measurements, (2) 
utilize individual animal background information such as breed composition and age of 
dam to explain variation among carcass measurements, (3) investigate the effect of 
vaccine protocol and traditional respiratory disease response measurements such as 
presence of clinical symptoms and pyrexia on carcass outcomes, and (4) evaluate 
possible relationships among the independent variables of lung scores, clinical 
symptoms, average daily gain classification, intake classification, and temperament 
classification. 
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MATERIALS AND METHODS 
All animal methods and protocols were approved by the Texas A&M University 
Institutional Animal Care and Use Committee and the Texas A&M University 
Institutional Biosafety Committee. 
Animals 
 Half-blood Angus-Nelore (F2 and F3) yearling steers sourced from the Texas 
A&M University McGregor Genomics herd were utilized. This population is a Bos 
taurus- Bos indicus crossbred population developed for genomic studies. F2 steers were 
made in 4 possible combinations of F1 matings, where Angus-sired (AN) and Nellore-
sired (NA) F1 sires were mated to AN and NA F1 females to produce F2 progeny, noted 
as ANAN, ANNA, NAAN, and NANA throughout this study. F3 steers were produced 
through mating F2 NANA sires to F2 NANA dams. Both F2 and F3 steers were born and 
evaluated in all four years of the study. Frequency distribution of animals through all 
four years of the study are presented below in Table 1. 
Table 1. Frequency distribution of calf types across years of the present study. 
Year NANA ANAN NAAN ANNA F3 Total 
2010 10 . . 14 51 75 
2011 20 4 12 16 51 103 
2012 11 9 9 16 51 96 
2013 18 9 10 14 33 84 
Total 59 22 31 60 186 358 
Labels across columns denote breed makeup of calves, with the first two letters 
denoting the sire’s breeding, and the second two denoting the dam’s. F3 calves were 
made by crossing F2 NANA animals. Labels across rows denote age of dam of the 
steers evaluated.
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Steers utilized in this study were spring-born in 2009, 2010, 2011, and 2012. 
Steers were castrated and vaccinated for clostridial diseases, but were not vaccinated 
against bovine respiratory disease (BRD) pathogens prior to weaning. Steers were 
vaccinated for clostridial diseases, and were weaned at approximately 7 months of age. 
Each year, steers were subjectively evaluated for temperament approximately 6 
weeks post-weaning by a panel of four evaluators on a 1-to-9 scale where 1 = animal 
was totally calm, quiet, and non-reactive when isolated, and 9 = animals that were highly 
aggressive, reactive, and a potential health threat to themselves and evaluators. These 
procedures and analyses were reported by Riley et al. (2014). While temperament was 
investigated as a potential source of variation among carcass traits in preliminary 
models, it was not included in final models because it was not found to be a significant 
contributor to variance in carcass traits.  
Post-weaning, calves were managed as one group where they were either fed a 
growing ration or placed on pasture, depending on the year, until they were transported 
approximately 165 km to the Beef Cattle Systems Research Unit near College Station, 
TX in either January or February. Throughout this study, low-stress cattle handling 
methods were emphasized during movement, processing, and data collection. 
All steers were tested and confirmed to be free of BVDV persistent infection via 
ear notch sampling. Ear notch samples were tested through immunohistochemistry or 
antigen-capture ELISA, and steers were confirmed to be seronegative for BVDV 
antibodies through serum virus neutralization assay. Immunological testing was 
performed by the Texas Veterinary Medical Diagnostic Laboratory (TVMDL, Amarillo, 
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TX). These assays and their corresponding results were described in detail by Downey-
Slinker et al. (2016).  
Vaccine treatments 
Steers were stratified by sire and genomics cow family of the McGregor 
Genomics population, which created the designation of “calf type” in the present study. 
Steers were assigned to one of three BRD vaccine strategies, which utilized modified-
live (MLV), killed (KV), or no (NON) vaccine treatment, administered at approximately 
12 months of age. Steers receiving KV had an initial dose of Vira Shield® (Novartis 
Animal Health US, Inc., Greensboro, NC) injection on d -56 or -49 pre-challenge, and a 
booster on d -35, -28, or -25, relative to viral challenge, targeting 21 d between primer 
and booster vaccinations. Steers receiving MLV were vaccinated with one dose of 
Arsenal® 4.1 (Novartis Animal Health US, Inc., Greensboro, NC) on d -35, -28, or -25 
relative to challenge, in concurrence with the administration of the KV booster. Both KV 
and MLV of vaccines are licensed to aid in control of infectious bovine rhinotracheitis 
(IBR), parainfluenza-3 (PI-3), bovine respiratory syncytial virus (BRSV), and BVDV. 
The same vaccines were used in all years. Steers assigned to the non-vaccinate treatment 
(NON) did not receive viral vaccination nor a sham injection prior to BVDV challenge. 
Steers receiving MLV were kept separated, with no nose-to-nose contact possible, from 
KV and NON-treated steers for 7 to 10 following MLV injection. Treatment groups 
were commingled within pens following this initial separation.  
Viral challenge  
Steers were challenged on d 0 with a non-cytopathic type 1b BVDV strain 
(CA0401186a) obtained from the USDA-ARS National Animal Disease Center (NADC) 
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(Ridpath et al., 2007). This strain was isolated from a persistently infected (PI) calf and 
submitted to the NADC from the Tulare laboratory of California Animal Health and 
Food Safety Laboratory. Each steer was administered 5 mL of inoculum (1 x 10
5 
TCID/mL) by placing 2.5 mL in each nasal passage; each animal’s nose was raised until 
it was visually observed that the steer had swallowed, confirming the challenge virus had 
passed through the nasal sinuses. The particular strain of BVDV was chosen because it 
had been reported to cause observable but mild clinical signs of morbidity monitored in 
the present study without risk of extreme morbidity or mortality. (Ridpath et al., 2007). 
Additionally, BVDV type 1b has been reported as the most prevalent strain in morbid 
North American feedlot cattle (Hilton, 2014).  
Sample and data collection 
Body weights and rectal temperatures were recorded on d 0 (day of challenge), 3, 
7, 10, 14, 28, and 42. Pyrexia classification in the present study (rectal temperatures ≥ 
40ºC = pyrexia) was determined from observed rectal temperatures on d 3, 7, 10, and 14. 
Order of processing (pen sequence) was rotated during processing across sample 
collection days to prevent potential confounding sequence with responses. 
Daily feed intake and feeding performance were recorded through the 
GrowSafe (Growsafe, Ltd., Calgary, AB, Canada) automated collection system, which 
records data from midnight to midnight daily. Diet composition and results regarding 
daily feed intake and behavior were described in detail by Smith et al. (2017). These data 
were utilized to determine cumulative feed intake, which in turn was investigated for 
influence on carcass merit.  
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Clinical observations were conducted twice daily for the first 14-day period, and 
then once daily for d 14 to 42, with a scoring system from 0 (no clinical symptoms), or 1 
to 5 (least to most severe) for commonly associated symptoms of BRD/BVD, including 
cough, ocular and nasal secretion, depression, diarrhea, and gauntness/shrink. The 
threshold for potential therapeutic treatment in which an animal would be removed from 
its pen was any observed clinical symptoms scoring 3 or above. No steers in the present 
study were identified as having clinical symptoms severe enough to warrant potential 
therapeutic treatment. Animals exhibiting rectal temperatures greater than 40.0ºC were 
administered tulathromycin (Draxxin, Zoetis, Parsnippany Hills, NY, U.S.)  according to 
label directions, regardless of the presence of clinical symptoms. This practice was done 
in accordance with the animal use protocol (AUP) of the project. The same personnel 
evaluated cattle in all 4 years of the project. Following challenge and the subsequent 42d 
feeding period, steers were transported 210km from Texas A&M’s experimental feedlot 
to a commercial feedlot in South Texas for finishing.  
 Upon arrival at the feedlot, cattle received booster vaccinations for BRD and 
clostridial diseases, injectable parasiticide, and a long-acting growth implant. Cattle also 
had tail switches bobbed and horns tipped if needed. Each year steers were housed in a 
single pen and transitioned from a receiving diet to a finishing diet over a 21-d period; 
cattle were placed on feed for approximately 150 to 180 d prior to harvest depending on 
the year. Steers were scheduled for harvest when the feedlot management observed 
adequate external fat cover and decreasing feed intake. All steers were presented for 
slaughter on the same day within a year.  
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 Steers were transported from the feedlot at approximately 0700 on day of 
harvest, 225 km to a commercial beef packing plant. At harvest, lungs were visually 
evaluated with a subjective 1-to-5 scale where: 1= pink, healthy lung with no 
discoloration, 2 = < 25% discoloration, 3 = 25% to 50% discoloration, 4 = 50% to 75% 
discoloration, and 5 = >75% discoloration. Carcasses were graded after approximately 
48-h of chilling by Texas A&M University meat science personnel, collecting carcass 
weight, longissimus muscle area, 12th rib fat thickness, KPH fat percentage, marbling 
score, lean maturity, skeletal maturity, lean color, and hump height.  
Statistical analyses 
All statistical analyses were carried out using mixed model procedures in SAS 
9.4 (SAS Inst. Inc., Cary, NC). Preliminary models were evaluated to investigate fixed 
effects of year, calf type, vaccine treatment, lymphocyte decline, pyrexia status, clinical 
signs, feeding performance, age of dam, and d 0 weight (as a covariate). These 
preliminary models were created by including all effects of interest within a category 
(health traits, and individual animal traits) in conjunction with weight gain ranking, and 
then cumulative feed intake ranking, For each carcass trait, full models were evaluated 
and subsequently altered where the effects with largest, non-significant P-values were 
removed one at a time until only variables that approached significance (P ≤ 0.15) 
remained for final models. Sire and pen nested within year were included as random 
effects in all final models. The animal traits associated with BRD morbidity that have 
been documented in other studies were of interest as potential independent variables to 
evaluate differences in the response variables of hot carcass weight, longissimus muscle 
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area, marbling score, and adjusted fat thickness. These response variables will be 
referred to as “carcass merit” through the remainder of the present study. 
Relationships between independent variables were also evaluated and presented 
through frequency distributions, which were tested through Chi-square tests. No two-
way distributions among these variables were different (P < 0.05) from the overall, 
single factor distributions and, thus, further evaluations were not conducted on these 
relationships.  
Preliminary Models Incorporating Health Traits 
 Lymphocyte decline, pyrexia status, vaccine type, and clinical signs were 
utilized in the present study to evaluate individual animal health outcomes. Lymphocyte 
decline was gathered as a continuous variable, but evaluated in accordance with 
Downey-Slinker et al. (2016), with steers having a lymphocyte decline greater than 40% 
being classified as “yes” and steers having a lymphocyte decline less than 40% being 
classified as “no” for the variable “lymdecline”. Pyrexia status classified in a similar 
fashion, with steers having an observed rectal temperature ≥ 40C in the first 14 days 
being classified as “yes” and steers not presenting rectal temperature ≥ 40C in the first 
14 days being classified as “no” for pyrexia.  
Clinical symptoms were evaluated on a scale from 0-to-5 scale, with 1 being the 
least severe symptoms, and 5 being the most severe. Steers having a score ≥ 1 for any 
observed clinical symptoms being classified as “yes” for clinical signs, and steers having 
a 0 for all clinical symptoms being classified as “no” for clinical signs. These clinical 
symptoms include cough, nasal and ocular discharge, depression, diarrhea, and 
gauntness/shrink. No steers in this study presented clinical symptoms that scored higher 
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than 2 on this scale, likely due to the chosen strain of BVDV. Frequency distribution of 
steers among these classifications are described in Table 2 below.  
Table 2. Frequency distribution of steers across health measures 
 Pyrexia
1 Clinical Symptoms2 Lymdecline3 
Yes 219 50 156 
No 143 312 200 
Total 362 362 356 
1No = no rectal temperature ≥ 40 C observed in the first 14 days, Yes = rectal 
temperature ≥ 40 C observed in the first 14 days. 2No = no sign of morbidity in the 
first 14 days, Yes = any sign of morbidity in the first 14 days.3No = lymphocyte 
decline did not exceed ≥ 40% in the first 14 days,  Yes = lymphocyte decline of ≥ 40% 
in the first 14 days.  
 
Vaccine type was placed into preliminary models as well, as it was of interest to 
evaluate possible variation in carcass merit based on the type of vaccine administered. 
Frequency distribution of steers among these classifications are described in Table 2 
below. Frequency distribution of steers between vaccine types is described in Table 3 
below.  
Table 3. Frequency distribution of steers across vaccine treatments 
Vaccine Type KV MLV NON Total 
n 120 124 118 362 
KV = Killed Virus vaccine, MLV = Modified-Live Virus vaccine, NON = Control 
animals, not receiving vaccine treatment. 
 
Preliminary Models Incorporating Feeding Performance  
Steers had feeding performance evaluated utilizing a GrowSafe (Growsafe, 
Ltd., Calgary, AB, Canada) system, where DMI was continuously monitored. With this 
data, average daily gain (ADG) was calculated as total gain within the first 14 days 
divided by 14. Gain to feed ratio (G:F) was calculated as total gain within the first 14 
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days divided by total intake within the first 14 days. Summary statistics for ADG and 
Intake for the first 14 days are presented in Table 4 below.  
Table 4. Summary statistics for average daily gain and cumulative feed intake measured 
per animal d 0 to 14 post BVDV challenge.  
Variable1 Mean SD CV Minimum Maximum 
ADG kg/d 0.67 0.69 102.864 -1.88 3.05 
Intake, kg 57.92 12.66 21.867 13.74 97.49 
 
Each of these variables was subsequently split into five groups, targeting an 
equal number of animals in each, roughly 20% per level, providing the discrete category 
levels of  “lowest”, “low”, “average”, “high”, “highest”, corresponding to the respective 
levels of production traits. Previous research on these data (Runyan et al., 2017) 
documented highly variable levels in these performance traits during the 14 d post-
challenge, therefore it was of interest to investigate whether these performance 
differences might influence carcass traits 150 to 180 d later. Summary statistics for ADG 
and Intake for the first 14 days are presented in Table 4 below. Frequency distributions 
of ADG and intake in the first 14 days are described in Table 5 below. 
 
  
Table 5. Frequency distribution and range of feeding performance categories 
 Lowest Low Average High Highest 
ADG 78 63 80 61 77 
Range, 
lb/d -1.879 to 0.130 
0.195 to 
0.454 
0.518 to 
0.842 0.907 to 1.231 1.296 to 3.044 
Intake 72 72 74 73 71 
Range, 
kg 
13.737 to 
47.043 
47.134 to 
55.007 
55.043 to 
61.016 
61.211 to 
67.941 
68.227 to 
97.492 
Labels across columns denote ranking, with rankings assigned to create nearly equal 
distribution of animals. 
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Preliminary Models Investigating Individual Animal Background Traits  
Steers were stratified between treatments based on sire and genomics cow 
family, yielding the variable of “calf type” balanced across treatments. This variable was 
utilized to investigate potential differences between the different cross types of NANA, 
NAAN, ANAN, ANNA, and F3 steers.  
Temperament scores were assigned approximately 6wk after weaning on a 1-to-9 
scale (best to worst), and temperament categories were assigned as Calm (scores ≤ 3.80), 
Moderate(scores of 3.81 – 6.0), and Wild (scores ≥ 6.01). Frequency distributions of 
temperament categories are presented below in Table 6.  
Table 6. Frequency distribution of animal temperament classifications 
Temperament N Average score 
Calm 118 2.345 
Moderate 117 5.220 
Wild 122 7.014 
Temperament scores were assigned approximately 6wk after weaning on a 1-to-9 
scale (best to worst), and temperament categories were assigned from mean value 
± 0.5 SD as Calm (scores ≤ 3.80), Moderate(scores of 3.81 – 6.0), and Wild 
(scores ≥ 6.01).
 
 
Age of dam was also utilized to investigate potential effects on carcass merit. 
Age of dam categories were based on BIF (2018) guidelines. This classification placed 
steers into four separate groups, with ages of dams falling into the categories of “three”, 
“four”, “five-ten”, “eleven-seventeen” for the variable “AOD”. Frequency distribution of 
calf type by age of dam is shown below in Table 7. 
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Table 7. Frequency distribution of calf type across age of dam classification 
Calf Type 
Dam age, yr ANAN ANNA NAAN NANA F3 Total 
Three 6 4 14 3 15 42 
Four 9 11 8 5 29 62 
Five - Ten 5 11 6 6 142 170 
Eleven- Seventeen 2 34 3 43 0 82 
Total 22 60 31 57 186 356 
Labels across columns denote breed makeup of calves, with the first two letters 
denoting the sire’s breeding, and the second two denoting the dam’s. F3 calves were 
made by crossing F2 NANA animals.
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RESULTS AND DISCUSSION 
A general summary of the carcass and performance traits that were evaluated is 
presented in Table 8. Several traits of these steers were of interest to investigate for 
potential influences on carcass traits, and several of the frequency distributions across 
other experimental effects are discussed. 
 
Lung Scores at Harvest  
While not included in final models, lung scores were investigated as a potential 
source of variation in carcass outcomes in preliminary analyses. The distribution of lung 
scores across vaccine treatments is shown in Table 9. Distribution of lung scores did not 
differ across vaccines treatments. 
 
 
 
 
 
 
 
Table 8. Summary statistics of carcass traits analyzed in the present study. 
Variable1 Mean SD CV Minimum Maximum 
HCW, kg 375.14 42.50 11.330 264.85 529.48 
AFT, cm 1.55 0.58 37.498 0.30 3.96 
LMA, cm2 84.66 8.99 10.623 58.71 107.74 
Marbling 401.53 74.73 18.610 230 750 
1HCW = hot carcass weight, AFT = adjusted fat thickness, LMA = longissimus 
muscle area, Marbling score of 400 corresponds to Small00.  
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Table 9. Frequency distribution of lung scores by vaccine treatment group.  
  Lung Score    
Vaccine 
Treatment 1 2 3 4 Total 
Average   
lung score 
KV 30 62 24 3 119 2 
 0.252 0.521 0.202 0.025 0.331  
MLV 34 69 19 1 123 1.894 
 0.276 0.561 0.154 0.008 0.342  
NON 36 67 14 1 118 1.831 
 0.305 0.568 0.119 0.008 0.328  
 100 198 57 5 360  
KV = Killed Virus vaccine, MLV = Modified-Live Virus vaccine, NON = Control 
animals, not receiving vaccine treatment. Whole numbers represent animal counts, 
decimals below represent percent. 
 
Because differences in average lung scores were not statistically different 
between vaccine treatment groups, they were not included in the final model for 
investigation for impacts on carcass traits. Few lungs belonging to animals in this study 
had lung scores high enough to indicate prior illness; this corresponds to our assessment 
of clinical symptoms, of which none were observed to be severe enough to warrant 
removing an animal from its pen for potential therapeutic treatment. Frequency 
distributions of clinical symptoms across lung scores are displayed below in Table 10. 
Distribution of lung scores did not differ in the presence or absence of clinical 
symptoms. 
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Table 10. Frequency distribution of mild clinical symptoms across lung scores.  
   Lung score   
Clinical 
Symptoms1 1 2 3 4 Total 
Average 
lung score 
No 83 172 51 5 311 1.929 
 0.267 0.553 0.164 0.016 0.864  
Yes 17 26 6 0 49 1.776 
 0.347 0.531 0.122 0.000 0.136  
1No = no sign of morbidity, Yes = any sign of morbidity. Animals were evaluated 
twice per day by the same evaluator across all years. Only minor signs (1 or 2 on a 1- 
to -5 scale) of depression, coughing or gauntness were observed. Whole numbers 
represent animal counts, while decimals below represent row frequency. 
 It is thought that animals having  lung scores of 4 (or 5) likely indicate prior 
illness. Throughout many analyses (Thompson et al., 2006; Schneider et al., 2009), lung 
lesions without the presence of clinical symptoms have been documented and likely 
indicate subclinical BRD illness. As stated by Griffin (2014), subclinically ill animals 
suffer from condemnation of offal, lowered quality grades, and lower carcass weights, 
leading to an average of $19.44 per animal on feed not realized by feeders. The 
frequency distribution of the presence of clinical symptoms and the presence of pyrexia 
in steers is shown below in Table 11. Distribution of the presence or absence of clinical 
symptoms did not differ in the presence or absence of pyrexia.  
Table 11. Frequency distribution of mild clinical symptoms with pyrexia status 
 Clinical symptoms  
Pyrexia Yes No Total 
Yes 31 188 219 
 0.620 0.603 0.605 
No 19 124 143 
 0.380 0.397 0.395 
Total 50 312 362 
 0.138 0.862 100 
No = no sign of morbidity, Yes = any sign of morbidity. Animals were evaluated twice 
per day by the same evaluator across all years. Only minor signs (1 or 2 on a 1- to-5 
scale) of depression, coughing or gauntness were documented. 
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A typical symptom of BVDV infection is the presence of pyrexia, and 60.5% of 
the steers in this study met the therapeutic treshhold of ≥ 40.0 C; however, a low animal 
count in the cell that includes both the presence of mild clinical symptoms and pyrexia is 
likely due to rectal temperatures being taken and recorded at predetermined regular 
intervals (d 3, 7, 10, and 14 post-challenge), as well as no animals presenting greater 
than mild clinical symptoms. This finding, and the practice of rectal temperatures taken 
at predetermined intervals contrasts to typical industry practices, where animals may 
only have rectal temperatures evaluated if other clinical symptoms are present first. 
Additionally, as summarized by Griffin (2014), presence of clinical symptoms does not 
encompass animals who are suffering from subclinical illness during the feeding period, 
but are later identified through lung lesions.  
It was also of interest to find any associations between vaccine type and feeding 
performance immediately following BVDV exposure, however, these terms were also 
not included in the final models as they did not explain significant levels of variance for 
carcass merit. This finding corresponds to those by Gaspers et al. (2015) that type of 
vaccine caused different levels of antibody titers, but did not influence feeding behavior 
or average daily gain. Frequency distributions of vaccine type across intake and average 
daily gain rankings are illustrated below in Table 12. Distribution of ADG and Intake 
ranking did not differ across vaccine treatments based on Chi-square tests. 
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Table 12. Frequency distribution of vaccine type by average daily gain and intake 
rankings for the first 14d of the feeding period. 
Variable Vaccine Lowest Low Ave High Highest Total 
 KV 21 26 29 19 25 120 
  0.175 0.217 0.242 0.158 0.208 0.334 
 MLV 30 20 25 21 28 124 
ADG  0.242 0.161 0.202 0.169 0.226 0.345 
 NON 27 17 26 21 24 115 
  0.235 0.148 0.226 0.183 0.209 0.320 
 Total 78 63 80 61 77 359 
  0.217 0.176 0.223 0.170 0.214 1.00 
 KV 25 28 22 19 26 120 
  0.208 0.233 0.183 0.158 0.217 0.331 
 MLV 24 18 29 26 27 124 
Intake  0.194 0.145 0.234 0.210 0.218 0.343 
 NON 23 26 23 28 18 118 
  0.195 0.220 0.195 0.237 0.153 0.326 
 Total 72 72 74 73 71 362 
  0.199 0.199 0.204 0.202 0.196 1.00 
Labels across columns denote ranking, with rankings assigned to create nearly 
equal distribution of animals. KV = Killed Virus vaccine, MLV = Modified-Live 
Virus vaccine, NON = Control animals, not receiving vaccine treatment.
 
 
Temperament at Weaning 
Similar to lung scores, animal temperament at weaning was investigated as a 
potential source of variation among carcass merit traits, but was not found to be 
statistically significant, and was therefore not included in final models. Frequency 
distribution of temperament classifications across calf genetic types are described below 
in Table 13. Temperament distributions did not differ across calf type based on Chi-
square test. 
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Temperament score was also investigated as a potential source of variation for 
animal performance and feed intake following BVDV challenge. However, temperament 
classification distribution was not found to be statistically different among average daily 
gain or intake rankings based on Chi-square tests. Temperament classifications across 
intake and average daily gain rankings are presented below in Table 14. Distribution of 
ADG and Intake classification did not differ between temperament classifications.  
 
 
 
 
Table 13. Frequency distribution of temperament scores across calf types.
 
 ANAN ANNA F3 NAAN NANA 
Calm 6 18 71 7 17 
 0.273 0.300 0.382 0.226 0.298 
Moderate 10 19 57 11 19 
 0.455 0.317 0.306 0.355 0.333 
Wild 6 23 58 13 21 
 0.273 0.383 0.312 0.419 0.368 
Total 22 60 186 31 57 
 0.062 0.169 0.522 0.087 0.160 
Labels across columns denote breed makeup of F2 calves, with the first two letters 
denoting the sire’s breeding (AN = Angus-sired F1 sire), and the second two denoting 
the dam’s breeding (AN = Angus-sired F1 dam). F3 calves were made by crossing F2 
NANA parents. Temperament classifications were assigned to average temperament 
scores of Calm (scores ≤ 3.80), Moderate (scores of 3.81 – 6.0), Wild (scores ≥ 6.01). 
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  Investigation of these potential independent variables on carcass merit and the 
components of the final mixed model analyses for all carcass traits are shown below in 
Table 15. Results are discussed sequentially for each carcass trait. For each carcass trait, 
effects that were included in the final models had significance levels that warranted their 
inclusion (P <0.10) 
 
 
 
 
Table 14. Frequency distribution of temperament scores across intake and 
performance rankings.
 
Variable Temperament Lowest Low Ave High Highest Total 
 Calm 25 29 19 26 21 120 
  0.208 0.242 0.158 0.217 0.175 0.331 
 Mod 29 17 25 28 19 118 
Intake  0.246 0.144 0.212 0.237 0.161 0.326 
 Wild 18 26 30 9 31 124 
  0.145 0.210 0.242 0.073 0.250 0.343 
 Total 72 72 74 63 71 362 
 Calm 27 24 23 19 26 119 
  0.227 0.202 0.193 0.160 0.218 0.331 
ADG Mod 28 12 26 19 32 117 
  0.239 0.103 0.222 0.162 0.274 0.326 
 Wild 23 27 31 23 19 123 
  0.187 0.220 0.252 0.187 0.154 0.343 
 Total 78 63 80 61 77 359 
Labels across columns denote average daily gain ranking and intake, with rankings 
assigned to create nearly equal distribution of animals. Temperament classifications 
were assigned to average temperament scores of Calm (scores ≤ 3.80), Moderate 
(scores of 3.81 – 6.0), Wild (scores ≥ 6.01). 
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Table 15. Summary of significance for all main effects and interactions investigated to 
affect carcass traits investigated with P- values reported for fixed effects and variances 
reported for random effects.  
Effect1 Marbling HCW LMA AFT 
Year -- -- -- -- 
Calf type 0.023 -- -- -- 
Vac. type -- -- -- 0.016 
Lymphopenic -- -- -- -- 
Pyrexia -- -- -- -- 
Clinical Symptoms -- -- 0.005 -- 
INTK014r -- 0.019 -- -- 
ADG014r -- -- -- -- 
AOD -- -- -- -- 
Calf type  pyrexia 0.017 -- -- -- 
Calf type  vaccine 
type 
-- -- -- 0.069 
ADG  Clinical 
symptoms 
-- 0.054 0.035 -- 
Sire 0 78.965 0.028 0 
Pen(year) 0 0 0 0 
Residual 5424.86 8509.9 1.895 0.051 
1Fixed effects are listed in column 1. HCW = hot carcass weight, LMA = longissimus 
muscle area, AFT = average fat thickness, Lymphocpenic is discrete, taking the values 
of yes or no, based on > 40% lymphocyte decline, and ≤ 40% lymphocyte decline, 
respectively. Sire and pen within year were included in all models as random effects. 
Significance was found at P ≤ 0.05, but results with P ≤ 0.10 are presented and 
discussed for trends. Any effect included in the final model for a particular carcass 
trait has an associated P-value. 
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Hot Carcass Weight 
Differences in hot carcass weight were observed due to feed intake ranking 14 d 
post-challenge (P = 0.013) and presence of mild clinical signs (P = 0.018) Least squares 
means for hot carcass weight across feed intake ranking levels are shown in Figure 1.  
 
Figure 1. Hot carcass weight least squares means relative to feed intake category during 
first 14-d period post BVDV challenge. (Least squares means with different letters are 
different at P < 0.05.)  
 
Steers falling into the highest feed intake level post challenge had higher carcass 
weights than those that fell into average (P = 0.017), low (P = 0.043), and lowest (P = 
0.001) intake levels, with 24.0 kg difference between steers with lowest and highest feed 
intake ranking post challenge. Steers falling into the high intake ranking trended 
differently from the lowest group by 13.6 kg (P = 0.058), but not from the highest, 
average, or low intake levels. 
While no animals in our study were identified as requiring potential therapeutic 
treatment based on severity of clinical symptoms, it should be noted that Wilson et al. 
(2017) identified a linear relationship between hot carcass weight and number of 
treatments (P < 0.001), with animals not identified as requiring treatment having an 
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average hot carcass weight of 372 kg, and steers receiving three or four treatments 
having an average hot carcass weight of 353 kg. A potential interaction between 
presence of mild clinical symptoms and average daily gain ranking was identified (P = 
0.054) for hot carcass weight. Interaction was likely driven by low animal numbers in 
some ADG levels, such as the “low” level of animals presenting clinical symptoms only 
having 2 animals, as well as a large standard error.  
 The finding of clinical BRD signs not affecting carcass weight in the present 
study appears to bein contrast to findings by several other studies. Schneider et al. 
(2009) reported that feedlot cattle of unspecified age and breed that were treated for 
BRD in the feedlot experienced a reduction in hot carcass weight of 8.2 kg, and is 
similar to findings by Roeber et al. (2001) on British and British/Continental crossbred 
animals. These contrasting results are likely due to the low level of virulence of our 
BVDV challenge strain, translating to animals only presenting mild clinical symptoms. 
Regardless of whether or not animals were identified as requiring therapeutic treatment 
at the hospital pen, Roeber et al. (2001) reported animals identified as having clinical 
symptoms of BRD two or more times had 9.2 kg lighter hot carcass weights than 
animals who were not removed to hospital pens; however, in our data, no cattle had 
clinical signs to the degree that animals would have been pulled from pens for potential 
therapeutic treatment, which is likely why we did not find a similar relationship. Holland 
et al. (2010) identified increasing number of BRD therapeutic treatments corresponded 
to decreases in hot carcass weight among British or British/Continental crossbred 
heifers, with animals being treated zero times, once, or twice having corresponding hot 
carcass weights of 343kg, 337kg, and 334kg, respectively (P = 0.03). Our findings are in 
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contrast to Garcia et al. (2010), where no difference was observed (P = 0.12) for hot 
carcass weight among crossbred steers containing Bos-indicus influence and slaughtered 
at approximately 14 months of age, based on a “treated” vs. “untreated” classification for 
BRD illness. 
The difference in findings between our study and Garcia et al. (2010) may have 
been due in part to differences in diagnosis or severity of clinical symptoms. A 
frequency table describing the relationship between intake ranking and ADG by mild 
clinical symptoms can be found in Table 16 below. A Chi-square test of independence 
was run for these variables, and distribution of clinical symptoms was not independent 
of feeding performance for DMI or ADG (P < .001 for both). Of the animals that 
presented mild clinical signs, 38% were in the lowest DMI ranking level, and 42% were 
in the lowest ADG ranking level; among the animals that did not present clinical signs, 
17% were in the lowest DMI ranking level, and 18% were in the lowest ADG ranking 
level. This further substantiates findings that feeding performance can be utilized as a 
tool for early diagnosis of morbidity, and that morbidity will negatively impact feeding 
behavior (Sowell et al., 1999; Kayser and Hill, 2013; Smith et al., 2017).  
 
 
 
 
 
 
 
  41 
Table 16. Frequency distribution of mild clinical symptoms across ADG and intake 
rankings. 
Variable Clinical 
Symptoms1 Lowest Low Ave High Highest Total 
 Yes 19 9 13 5 4 50 
Intake  0.38 0.18 0.26 0.1 0.08 0.138 
 No 53 63 61 68 67 312 
  0.169 0.202 0.196 0.218 0.215 0.862 
 Total 72 72 74 73 71 362 
  0.199 0.199 0.204 0.202 0.196 100 
 Yes 21 2 6 8 13 50 
ADG  0.42 0.04 0.12 0.16 0.26 0.139 
 No 57 61 74 53 64 309 
  0.184 0.197 0.239 0.172 0.207 0.861 
 Total 78 63 80 61 77 359 
  0.217 0.176 0.223 0.170 0.214 100 
1Evaluated on a scale of 0 = no clinical signs (No) and 1 to 5 = mild to severe 
presence of ocular secretion, nasal discharge, lethargy, or diarrhea; steers in this 
project exhibited mild clinical signs (1 and 2), with no animals exhibiting clinical 
signs high enough (3 or greater) to warrant pulling animals from pens for potential 
therapeutic treatment. 
 
Marbling Score 
Differences in marbling were observed due to differences in calf type (P = 
0.023), as well as an interaction between calf type and presence of pyrexia (P = 0.017). 
Least squares means for marbling score units by calf type are shown in Figure 2 below.  
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Figure 2. Marbling score least squares means relative to calf type. (Labels on x-axis 
denote breed makeup of calves, with the first two letters denoting the sire’s breeding, 
and the second two denoted the dam’s. F3 calves were made by crossing F2 NANA 
animals. Least squares means with different letters are different at P < 0.05.)  
 
Differences in marbling were observed when comparing calf types to one 
another. Across these calf types, ANAN steers were different from NANA, NAAN, and 
ANNA steers (P = 0.028, 0.025 and 0.002, respectively), having a 42.8, 48.9, and 59.7 
more marbling score units, respectively. The ANAN steers also showed a trend of 
having differences from F3 steers (P = 0.055), with 34.0 more marbling score units on 
average. Similarly, ANNA calves were found have differences in marbling from F3 
calves (P = 0.021), with 25.7 lower marbling score units, but was not found to be 
different from NANA, or NAAN calves, with NAAN calves also not showing 
differences from NANA calves. It is of interest to note that calf type did not affect hot 
carcass weight, adjusted fat thickness, or longissimus muscle area.  
 
An interaction was identified for marbling (P = 0.017) between pyrexia status 
and calf type. Steers exhibiting rectal temperatures greater than 40°C within 14 d 
following BVDV exposure were classified as exhibiting pyrexia, while steers that were 
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not found to exhibit a rectal temperature greater than 40°C at any time during the study 
were classified as not exhibiting pyrexia. The least squares means for this interaction are 
shown in Figure 3.  
 
Figure 3. Marbling least squares means relative to presence of pyrexia and calftype. 
(Pyrexia status was classified on animals presenting rectal temperatures greater than 
40C at any time during the first 14 d following BVDV challenge. Labels on x-axis 
denote breed makeup of calves, with the first two letters denoting the sire’s breeding, 
and the second two denoted the dam’s. F3 calves were made by crossing F2 NANA 
animals.) 
 
This interaction is likely driven by the large difference seen for pyrexia status in 
NAAN steers, in which case steers not presenting with pyrexia had 54.1 marbling score 
units less marbling than steers that did present with pyrexia (P = 0.051); this goes 
against the trend seen among other calf types, where there were no differences or slightly 
higher marbling scores among steers that did not present with pyrexia. Steers that 
exhibited pyrexia had a tendency (P = 0.065) to deposit less intramuscular fat than steers 
that did not exhibit pyrexia when feed intake ranking was included in the model. A 
frequency table describing the distribution of calf type by pyrexia status can be seen 
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below in Table 17. The distribution of pyrexia status was not different across calf type 
based on Chi-square test 
Table 17. Frequency distribution of calf type by pyrexia status 
Pyrexia1 ANAN ANNA NAAN NANA F3 Total 
Yes 15 33 20 31 115 214 
 0.070 0.154 0.093 0.145 0.537 0.601 
No 7 27 11 26 71 142 
 0.049 0.190 0.077 0.183 0.500 0.399 
Total 22 60 31 57 186 356 
1Pyrexia status was determined by steer presenting rectal temperature > 40° C at any 
time. Labels across the top denote breed makeup of calves, with the first two letters 
denoting the sire’s breeding, and the second two denoted the dam’s. F3 calves were 
made by crossing F2 NANA animals. 
 
 
Longissimus Muscle Area 
 Differences in longissimus muscle area were observed due to presence of mild 
clinical symptoms (P = 0.005). Least squares means for these categories are shown 
below in Figure 4.  
 
Figure 4. Longissimus muscle area in cm2 relative to presence of mild clinical symptoms 
during the 14d following BVDV challenge 150 to 180d prior to harvest. (No = no sign of 
morbidity, Yes = any sign of morbidity. Animals were evaluated twice per day by the 
same evaluator across all years. Only minor morbidity signs were documented, classified 
as scores of 1 or 2 on a 1- to-5 scale for depression, ocular/nasal discharge, coughing, 
diarrhea, or gauntness.)  
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Differences in longissimus muscle area were found (P = 0.005), with steers 
exhibiting mild clinical symptoms typical of BRD infection, with steers not showing 
clinical symptoms having 4.98 cm2 greater longissimus muscle area.. While no animals 
presented clinical symptoms severe enough to warrant removal from pen for potential 
therapeutic treatment, these findings are consistent with Wilson et al. (2017), who found 
a linear relationship between loin muscle area (LMA) and number of antimicrobial 
treatments associated with BRD symptoms, with animals having 91.8 cm2 93.9cm2, 
90.8cm2, and 87.3cm2 loin muscle area after being treated zero times, once, twice, or 
three/four times, respectively (P = 0.05).  
An interaction was found for longissimus muscle area (P = 0.035) involving the 
presence of clinical symptoms and average daily gain level. Least squares means for this 
interaction are shown in Figure 5.  
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  No:             57                61                    74       53       64 
 Yes:             21                  2           6        8       13 
Figure 5. Longissimus muscle area in cm2 relative to the interaction of average daily 
gain level immediately following BVDV exposure and clinical symptoms. (Numbers 
beneath the legend indicate animal counts within the rankings by presence or absence of 
clinical symptoms. Average daily gain rankings of “Low” and “Highest” differ (P < 
0.10).
 
No = no sign of morbidity, Yes = any sign of morbidity. Animals were evaluated 
twice per day by the same evaluator across all years. Only minor morbidity signs were 
documented, classified as scores of 1 or 2 on a 1- to-5 scale for depression, ocular/nasal 
discharge, coughing, diarrhea, or gauntness.) 
 
While not significant at the 0.05 level, a trend has been shown to occur within 
least squares means for the “low” and “highest” average daily gain rankings (P = 0.070, 
0.062), with steers not presenting clinical symptoms having 7.5 and 5.6 cm2 greater 
LMA respectively, than steers that did not to interact with the presence of clinical signs 
for LMA, which is likely being driven by low animal counts and large standard errors 
within these rankings, with only 2 and 13 animals presenting with mild clinical 
symptoms in the “low” and “highest” categories, respectively.  
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Adjusted Fat Thickness 
Differences in adjusted fat thickness were found (P = 0.016) for vaccine type. 
Steers receiving MLV treatment had 0.26 cm lower adjusted fat thickness than those 
receiving KV treatment, but did not differ from steers in the non-vaccinated group. 
These least squares means are shown in Figure 6. 
 
Figure 6. Adjusted fat thickness least squares means relative to vaccine treatment. (Least 
squares means with different letters are different at P < 0.05.) 
 
While differences due to vaccine type were found for adjusted fat thickness, an 
interaction trend was identified between calf type and vaccine type (P = 0.069). 
Although vaccine treatments were assigned within individual sires, this effect may be 
driven, at least in part, by low animal counts in some calf types; F3 calves represented 
approximately half of all animals in this project. Frequency distributions of vaccine type 
and calf type are shown in Table 18. Our findings that clinical symptoms were not a 
significant contributor to adjusted fat thickness is in contrast to Roeber et al. (2001), who 
found that identification of clinical symptoms in individual animals severe enough to 
warrant removal to hospital pens two or more times during the feeding period caused 
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adjusted fat thickness to decrease 0.17 cm when compared to animals who were not 
identified to potential therapeutic treatment. However, it is likely this may be due to the  
classification of animals in our study, of which, none were identified as having clinical 
symptoms severe enough to warrant removal from the pen for possible therapeutic 
treatment as only mild clinical symptoms were documented, and these were only in 14% 
of animals. It is not clear why vaccine differences would exist for adjusted fat thickness 
but not carcass weight or marbling score.  
Table 18. Frequency distribution of vaccine treatment by calf type. 
 ANAN ANNA F3 NAAN NANA Total 
KV 8 21 59 10 20 118 
 0.068 0.178 0.500 0.085 0.169 1.000 
MLV 8 21 64 10 10 123 
 0.065 0.171 0.520 0.081 0.081 1.000 
NON 6 18 63 11 17 115 
 0.052 0.157 0.548 0.096 0.148 1.000 
Total 22 60 186 31 47 356 
 0.062 0.169 0.522 0.087 0.132 1.000 
Whole numbers represent animal counts, while decimals below represent percent of 
animals within that row. Labels across the top denote breed makeup of calves, with the 
first two letters denoting the sire’s breeding, and the second two denoted the dam’s. F3 
calves were made by crossing F2 NANA animals. KV = Killed Virus vaccine, MLV = 
Modified-Live Virus vaccine, NON = Control animals, not receiving vaccine treatment. 
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SUMMARY 
 The objectives of this study were to evaluate differences in traditional carcass 
traits based on bovine respiratory disease vaccination protocol and health responses in 
the first 14 days following bovine viral diarrhea virus (BVDV) type 1b challenge, and to 
investigate calf background effects of sire, type of cross, pyrexia status, presentation of 
clinical symptoms, temperament, and any interactions of health responses. The results of 
this study support these objectives, and have brought greater insight to the relationships 
between events occurring early in the feeding period when animals can be exposed to 
pathogens, as well as individual animal background information, and how these 
influences may impact beef carcass merit. 
 Although 60.5% of the animals in this study presented with pyrexia (> 40.0 C) 
in the 14 d following BVDV exposure, this factor alone did not explain differences in 
carcass merit 150 to 180 days later after finishing. Additionally, 13.8% of the animals 
presented any clinical signs of morbidity, and these signs were not severe enough to 
warrant potential therapeutic treatment; however presence of these mild clinical 
symptoms accounted for significant differences in longissimus muscle area.   
This study showed that vaccine influenced adjusted fat thickness (P = 0.016); 
modified live virus steers had 0.26 cm lower adjusted fat thickness than killed virus 
steers, yet did not affect other carcass traits. Marbling was affected by type of cross (P = 
0.023) with up to 0.60 marbling scores higher (P < 0.05) in some parental combinations; 
an interaction between type of cross and pyrexia status also affected marbling (P = 
0.017), with one parental combination having higher marbling associated with pyrexia; 
calf type did not explain variation in other carcass traits. Hot carcass weight was not 
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affected by pyrexia, but was affected by feed intake during the 14 d period following 
BVDV challenge (P = 0.019), with steers in the highest vs. lowest category averaging 
24.0kg heavier, although no animals presented morbidity symptoms severe enough to 
warrant potential therapeutic treatment, yet presence of mild clinical symptoms affected 
ribeye area (P = 0.005), resulting in 4.98 cm2 lower ribeye area, but this pattern was 
inconsistent among feed intake levels.  
This study affirms the complexity of health impacts on beef carcass traits and the 
need for improved study of subclinical illness in beef production systems. While the 
results from this study have increased the knowledge base of the bovine respiratory 
disease complex and bovine viral diarrhea, further research is warranted on potential 
variation in marbling caused by type of cross and a standardized system of diagnosing 
and describing subclinical illness across animal types and herds. 
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